Cargando…
Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome
Negative consequences and medical complications of COVID-19 can persist for up to several months after initial recovery. These consequences can include stroke, diabetes, decreased lung diffusing capacity, sleep apnea, pulmonary fibrosis, arrhythmia, myocarditis, fatigue, headaches, muscle aches, hea...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821575/ https://www.ncbi.nlm.nih.gov/pubmed/36615108 http://dx.doi.org/10.3390/jcm12010308 |
_version_ | 1784865730339012608 |
---|---|
author | Kitala, Diana Łabuś, Wojciech Kozielski, Jerzy Strzelec, Przemysław Nowak, Mariusz Knefel, Grzegorz Dyjas, Piotr Materniak, Krzysztof Kosmala, Jolanta Pająk, Jolanta Czop, Jolanta Janda-Kalus, Barbara Marona, Barbara Nowak-Wróżyna, Anna Gierek, Marcin Szczegielniak, Jan Kucharzewski, Marek |
author_facet | Kitala, Diana Łabuś, Wojciech Kozielski, Jerzy Strzelec, Przemysław Nowak, Mariusz Knefel, Grzegorz Dyjas, Piotr Materniak, Krzysztof Kosmala, Jolanta Pająk, Jolanta Czop, Jolanta Janda-Kalus, Barbara Marona, Barbara Nowak-Wróżyna, Anna Gierek, Marcin Szczegielniak, Jan Kucharzewski, Marek |
author_sort | Kitala, Diana |
collection | PubMed |
description | Negative consequences and medical complications of COVID-19 can persist for up to several months after initial recovery. These consequences can include stroke, diabetes, decreased lung diffusing capacity, sleep apnea, pulmonary fibrosis, arrhythmia, myocarditis, fatigue, headaches, muscle aches, heart rate fluctuations, sleep problems, memory problems, nervousness, anxiety, and other neurological disorders. Thirty-one patients who reported symptoms related to previous COVID-19 disease of both sexes were enrolled in the initial program. The patients underwent compression sessions in a multiplace hyperbaric chamber. Each patient underwent a cycle of 15 compressions. Before the first session, each participant completed a venous blood gas test, a Fullerton test, and two spirometry tests (one before the Fullerton test and one after the test). Patients completed psychotechnical tests, a questionnaire on quality of life (Polish version of EQ-5D-5L), and a questionnaire on specific symptoms accompanying the disease and post-infection symptoms. The results showed significant improvements in areas such as quality of life, endurance and strength, some spirometric parameters, the anion gap and lactate levels, working memory, and attention in the group of treated patients. In contrast, there were no changes in pH, pO2, pCO2, glucose, and excess alkaline values. A follow-up interview confirmed that the beneficial effects were maintained over time. Considering the results obtained, including the apparent improvement in the patient’s clinical condition, it can be concluded that the use of 15 compression sessions was temporarily associated with a noticeable improvement in health and performance parameters as well as improvement in certain blood gas parameters. |
format | Online Article Text |
id | pubmed-9821575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98215752023-01-07 Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome Kitala, Diana Łabuś, Wojciech Kozielski, Jerzy Strzelec, Przemysław Nowak, Mariusz Knefel, Grzegorz Dyjas, Piotr Materniak, Krzysztof Kosmala, Jolanta Pająk, Jolanta Czop, Jolanta Janda-Kalus, Barbara Marona, Barbara Nowak-Wróżyna, Anna Gierek, Marcin Szczegielniak, Jan Kucharzewski, Marek J Clin Med Article Negative consequences and medical complications of COVID-19 can persist for up to several months after initial recovery. These consequences can include stroke, diabetes, decreased lung diffusing capacity, sleep apnea, pulmonary fibrosis, arrhythmia, myocarditis, fatigue, headaches, muscle aches, heart rate fluctuations, sleep problems, memory problems, nervousness, anxiety, and other neurological disorders. Thirty-one patients who reported symptoms related to previous COVID-19 disease of both sexes were enrolled in the initial program. The patients underwent compression sessions in a multiplace hyperbaric chamber. Each patient underwent a cycle of 15 compressions. Before the first session, each participant completed a venous blood gas test, a Fullerton test, and two spirometry tests (one before the Fullerton test and one after the test). Patients completed psychotechnical tests, a questionnaire on quality of life (Polish version of EQ-5D-5L), and a questionnaire on specific symptoms accompanying the disease and post-infection symptoms. The results showed significant improvements in areas such as quality of life, endurance and strength, some spirometric parameters, the anion gap and lactate levels, working memory, and attention in the group of treated patients. In contrast, there were no changes in pH, pO2, pCO2, glucose, and excess alkaline values. A follow-up interview confirmed that the beneficial effects were maintained over time. Considering the results obtained, including the apparent improvement in the patient’s clinical condition, it can be concluded that the use of 15 compression sessions was temporarily associated with a noticeable improvement in health and performance parameters as well as improvement in certain blood gas parameters. MDPI 2022-12-30 /pmc/articles/PMC9821575/ /pubmed/36615108 http://dx.doi.org/10.3390/jcm12010308 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kitala, Diana Łabuś, Wojciech Kozielski, Jerzy Strzelec, Przemysław Nowak, Mariusz Knefel, Grzegorz Dyjas, Piotr Materniak, Krzysztof Kosmala, Jolanta Pająk, Jolanta Czop, Jolanta Janda-Kalus, Barbara Marona, Barbara Nowak-Wróżyna, Anna Gierek, Marcin Szczegielniak, Jan Kucharzewski, Marek Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title | Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title_full | Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title_fullStr | Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title_full_unstemmed | Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title_short | Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome |
title_sort | preliminary research on the effect of hyperbaric oxygen therapy in patients with post-covid-19 syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821575/ https://www.ncbi.nlm.nih.gov/pubmed/36615108 http://dx.doi.org/10.3390/jcm12010308 |
work_keys_str_mv | AT kitaladiana preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT łabuswojciech preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT kozielskijerzy preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT strzelecprzemysław preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT nowakmariusz preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT knefelgrzegorz preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT dyjaspiotr preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT materniakkrzysztof preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT kosmalajolanta preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT pajakjolanta preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT czopjolanta preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT jandakalusbarbara preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT maronabarbara preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT nowakwrozynaanna preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT gierekmarcin preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT szczegielniakjan preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome AT kucharzewskimarek preliminaryresearchontheeffectofhyperbaricoxygentherapyinpatientswithpostcovid19syndrome |